Variable | Â |
---|---|
Age ± SD [yrs] | 58,69 ± 12,61 |
Women/men n (%) | 47 (26,4%)/131 (73,6%) |
Cardiogenic shock n (%) | 131 (73,6%) |
Marfan syndrome n (%) | 2 (1,12%) |
Trauma prior to admission n (%) | 1 (0,56%) |
History of the cardiac or vascular surgery n (%) | 11 (6,18%) |
Prior AVR | 5 (2,81%) |
Prior CABG | 4 (2,25%) |
Prior abdominal aneurysm repair | 2 (1,12%) |
Type of cardiac surgery n (%) | Â |
Alloplasty of ascending aorta using composite aortic graft (Bental de Bono procedure) | 101 (58,72%) |
Alloplasty of ascending aorta sparing aortic valve | 63 (36,63%) |
Alloplasty of aortic arch | 36 (20,93%) |
Aortic valve plasty | 5 (2,91%) |
CABG | 10 (5,81%) |
Stent-graft deployment in the descending aorta | 2 (1,16%) |
The brachio-cephalic trunk plasty | 2 (1,16%) |
MVR | 1 (0,58%) |
Deaths n (%) | 69 (38,76%) |
Preoperative | 6 (3,37%) |
Intraoperative | 30 (16,85%) |
Postoperative (before discharge) | 33 (18,54%) |
Echocardiographic findings | Â |
Aortic dissection n (%) | 159 (89,32%) |
Severe aortic dilatation (max. diameter ≥ 60 mm) n (%) | 60 (34,48%) |
LVEF ± SD [%] | 49,62 ± 11,97 |
LVEF ≤ 35% n (%) | 32 (18,39%) |
Regional wall motion abnormalities n (%) | 55 (31,6%) |
Cardiac tamponade n (%) | 48 (26,97%) |
Bicuspid aortic valve n (%) | 9 (5,06%) |
Calcification of the tricuspid aortic valve n (%) | 10 (5,62%) |
Moderate/severe aortic regurgitation n (%) | 53 (29,78%) |
Calcific mitral stenosis n (%) | 1 (0,56%) |